» Articles » PMID: 23039285

Prevalence and Risk Factors for VRE Colonisation in a Tertiary Hospital in Melbourne, Australia: a Cross Sectional Study

Overview
Publisher Biomed Central
Date 2012 Oct 9
PMID 23039285
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled:

Background: Vancomycin-resistant Enterococcus (VRE) has been established as a significant health-care associated problem since its first isolation in Australia in 1994. In this study, we measured the point prevalence and identified risk factors associated with vanB VRE colonisation in a tertiary care hospital in Melbourne, Australia where VRE has been endemic for 15 years.

Methods: A hospital-wide point prevalence survey was conducted on October 13, 2008 with colonisation detected using rectal swab culture. Patient's demographic and medical information was collected through a review of medical records. Factors associated with VRE colonisation in univariate analysis were included in multivariate logistic regression model to adjust for confounding.

Results: The prevalence of VRE colonisation on the day of screening was 17.5% (95% CI, 13.7 to 21.9). VRE was detected from patients in each ward with the prevalence ranging from 3% to 29%. Univariate analysis showed the use of any antibiotic, meropenem, ciprofloxacin, diarrhoea and longer length of hospital stay were associated with increased risk of VRE colonisation (p<0.05). However, age, sex, proximity to VRE positive cases, use of other antibiotics including cephalosporins, vancomycin were not associated with increased risk (P>0.05). Multivariate analysis showed the exposure to meropenem (p=0.004), age (≥65 years) (p=0.036) and length of stay ≥7 days (p<0.001) as independent predictors of VRE colonisation.

Conclusion: Our study suggests that exposure to antibiotics may have been more important than recent cross transmission for a high prevalence of vanB VRE colonisation at our hospital.

Citing Articles

Persistence of Daptomycin-Resistant and Vancomycin-Resistant Enterococci in Hospitalized Patients with Underlying Malignancies: A 7-Year Follow-Up Study.

El Haddad L, Angelidakis G, Zhai Y, Yaghi L, Arias C, Shelburne S Microorganisms. 2024; 12(8).

PMID: 39203518 PMC: 11356748. DOI: 10.3390/microorganisms12081676.


Genome analysis of multidrug resistant Enterococcus faecium and Enterococcus faecalis circulating among hospitalized patients in uMgungundlovu District, KwaZulu-Natal, South Africa.

Founou R, Founou L, Allam M, Ismail A, Essack S BMC Infect Dis. 2024; 24(1):671.

PMID: 38965470 PMC: 11225414. DOI: 10.1186/s12879-024-09380-3.


The intestinal carrier status of Enterococcus spp. in children: clonal diversity and alterations in resistance phenotypes before and after admission to a pediatric intensive care unit.

Shirvani F, Hassanzadeh R, Attaran B, Ghandchi G, Abdollahi N, Gholinejad Z BMC Pediatr. 2023; 23(1):434.

PMID: 37648974 PMC: 10466818. DOI: 10.1186/s12887-023-04238-0.


Previous antibiotic therapy as independent risk factor for the presence of vancomycin-resistant enterococci in surgical inpatients. Results from a matched case-control study.

MacKenzie P, Farber J, Post M, Esser T, Bechmann L, Kropf S BMC Infect Dis. 2023; 23(1):274.

PMID: 37131139 PMC: 10155433. DOI: 10.1186/s12879-023-08238-4.


Characteristics and outcomes of hospital-acquired and community-acquired peritonitis in patients on peritoneal dialysis: a retrospective cohort study.

Ling C, Sud K, Peterson G, Fethney J, Van C, Patel R J Nephrol. 2023; 36(7):1877-1888.

PMID: 36913080 PMC: 10543707. DOI: 10.1007/s40620-023-01597-w.


References
1.
DAgata E, Gautam S, Green W, Tang Y . High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2001; 34(2):167-72. DOI: 10.1086/338234. View

2.
Padiglione A, Wolfe R, Grabsch E, Olden D, Pearson S, Franklin C . Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother. 2003; 47(8):2492-8. PMC: 166086. DOI: 10.1128/AAC.47.8.2492-2498.2003. View

3.
Ballard S, Pertile K, Lim M, Johnson P, Grayson M . Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother. 2005; 49(5):1688-94. PMC: 1087664. DOI: 10.1128/AAC.49.5.1688-1694.2005. View

4.
Al-nassir W, Sethi A, Li Y, Pultz M, Riggs M, Donskey C . Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother. 2008; 52(7):2403-6. PMC: 2443881. DOI: 10.1128/AAC.00090-08. View

5.
MacIntyre C, Empson M, Boardman C, Sindhusake D, Lokan J, Brown G . Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol. 2002; 22(10):624-9. DOI: 10.1086/501833. View